ClinicalTrials.gov record
Recruiting Phase 1 Interventional

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

ClinicalTrials.gov ID: NCT05983432

Public ClinicalTrials.gov record NCT05983432. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 11:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1 Study Evaluating the Safety, Tolerability, and Efficacy of BL-B01D1 in Subjects With Metastatic or Unresectable Non-Small Cell Lung Cancer and Other Solid Tumors

Study identification

NCT ID
NCT05983432
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
SystImmune Inc.
Industry
Enrollment
470 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 7, 2023
Primary completion
Dec 30, 2026
Completion
Mar 20, 2028
Last update posted
Jan 28, 2026

2023 – 2028

United States locations

U.S. sites
24
U.S. states
15
U.S. cities
21
Facility City State ZIP Site status
Beverly Hills Cancer Center Beverly Hills California 90211 Recruiting
City of Hope Cancer Center Duarte California 91010 Recruiting
Chao Family Comprehensive Cancer Care and Ambulatory Care Irvine California 92612 Not yet recruiting
Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine California 92612 Not yet recruiting
University of California Irvine Medical Center Orange California 92868 Recruiting
UCLA Santa Monica Santa Monica California 90404 Recruiting
University of Colorado Cancer Center Aurora Colorado 80045 Recruiting
Yale University, Yale Cancer Center New Haven Connecticut 06520 Recruiting
Georgetown University Medical Center Washington D.C. District of Columbia 20007 Recruiting
Sylvester Comprehensive Cancer Center Miami Florida 33125 Recruiting
Sara Cannon Research Institute Lake Nona Orlando Florida 32827 Recruiting
Hematology - Oncology Associates of the Treasure Coast Port Saint Lucie Florida 34952 Recruiting
Northwestern University Feinberg School of Medicine Chicago Illinois 60611 Recruiting
University of Iowa Hospital and Clinics Iowa City Iowa 52242 Recruiting
Norton Cancer Institute Louisville Kentucky 40202 Recruiting
Massachusetts General Hospital Boston Massachusetts 02114 Recruiting
Dana-Farber Cancer Institute Boston Massachusetts 02215 Recruiting
Memorial Sloan Kettering Cancer Center Head Neck Services New York New York 10065 Recruiting
PRISMA Health/ITOR Greenville South Carolina 29605 Recruiting
Sarah Cannon - Tennessee Oncology Nashville Tennessee 37203 Recruiting
Oncology Consultants, P.A. Houston Texas 77030 Recruiting
University of Texas M.D. Anderson Cancer Center Houston Texas 77030 Recruiting
Virginia Cancer Specialists Fairfax Virginia 22031 Recruiting
University of Washington Fred Hutchinson Seattle Washington 98109 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05983432, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 28, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05983432 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →